The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
PTC THERAPEUTICS INC | Com | 69366J200 | 312,231 | 8,180 | SH | DFND | 0 | 312,231 | 0 | 0 | |
NU HOLDINGS LTD CAYMAN ISL A | Com | G6683N103 | 9,157,500 | 2,250,000 | SH | DFND | 0 | 9,157,500 | 0 | 0 | |
GRAB HOLDINGS LTD CL A | Com | G4124C109 | 20,428,327 | 6,344,201 | SH | DFND | 0 | 20,428,327 | 0 | 0 |